Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes. - Wikidata - wikimedia - TriplyDB

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

http://www.wikidata.org/entity/Q35641386

about

Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopes.Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.Demographics and natural history of HIV-1-infected spontaneous controllers of viremia.HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells.Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells.HLA class I-mediated HIV-1 control in Vietnamese infected with HIV-1 subtype A/E.Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype.CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication.Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control

P2860

Q33610621-3FDB0393-49BE-4C01-8653-66EF562B061D Q35861190-75AE2399-942C-4A28-95AF-E2FEA69BC212 Q36301732-54BC0974-C1B1-45C6-AC62-97E33651370B Q36624369-620C50AE-8A20-4483-9D54-6180C1CB328E Q36756865-9F02F47B-1EEE-4DA6-ABD7-135A1EB89471 Q36951283-90B4909A-F4F3-44E0-A1BB-4300E9DDD4CD Q37221660-31EAB158-F20B-404B-A4AA-E78B6DA70E9D Q38736699-3724C2C4-2A2D-4F32-A0E3-3445E555BFBF Q40118193-AE87D4B3-6500-44A6-9427-B8E88E124F0E Q40291456-E8017F7A-5909-4BFF-9EE8-1F1A05FBF02A Q40348395-BC6ECD18-A871-4046-BB0A-9680791DD3D7 Q40428899-5DB77770-877F-4EAA-931D-0B2747B6B671 Q45074789-00500DA1-07A4-49F4-84E4-F28F01684B3D Q46354970-FE22B601-CE98-4207-9D0B-DCF2E02986E1 Q47626019-507407C6-7570-4314-810A-04591ADCADF0 Q55517759-6971AB2E-FADF-4D6F-B1F4-E3D7782BADE2 Q57009763-EEFFC99F-1B62-4DCD-AA2B-DC2207BF65AF Q58572686-9A6DBB44-ED01-4EC7-9E30-71CCDA4B9AED Q58702145-048C8EF9-74E1-4280-A65B-D70FC17887CF

P2860

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

http://www.wikidata.org/entity/Q35641386

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

@ast

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

@en

type

label

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

@ast

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

@en

prefLabel

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

@ast

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

@en

P1433

Q35641386-71229CA5-7CDF-4976-93C1-746DDD6718E4

P1476

Q35641386-A6FFF432-EE90-4709-8DE4-B7D4AD6DE106

P2093

Q35641386-2F3E64F5-9F5E-40D4-A457-A00DE051B7BF

Q35641386-53CA22E8-0373-48BE-A2BF-E955EE62FDBB

Q35641386-84F1C146-DBC3-47BA-B3F9-6B87064DD983

Q35641386-8BE0D1A8-E864-4700-A7EC-A74ED63EF7B9

Q35641386-918AAAA3-EA36-42B1-BE95-6039F4724623

Q35641386-93EC7C08-930B-49E1-8033-0CA953FD457C

Q35641386-A3E9B828-A335-4632-9B27-B6E2BD6E00A3

Q35641386-A60DC3D4-7B67-49CD-B57D-6E84C48A5DA6

Q35641386-BD063958-938A-4747-B13E-D4C64243CA23

Q35641386-C88FDDDB-568D-4F4E-96DC-4A852C6128BC

P2860

Q35641386-02576272-C935-43EE-BACA-E505F5FAB326

Q35641386-03244DE7-8AAB-4826-8EDE-7621EB65F8B9

Q35641386-0A9F8380-FE2B-4ADA-BCA7-4A65F09C70FE

Q35641386-0D754DAB-38A0-4736-84D9-0F7C112FA556

Q35641386-0FA33758-9948-4B04-BF60-1F5839B8B4F2

Q35641386-11C4C26C-FA4C-4235-AD05-6D0F2A529DD2

Q35641386-199D3E44-E408-41EA-B3B2-09CE5B317A93

Q35641386-32BDB9AB-1C5C-4235-91EC-A50A1D07990E

Q35641386-32C71840-3746-4E26-8583-234D58F25720

Q35641386-33D622A2-3E86-4E70-9F81-5455812B0FFE

P304

Q35641386-7F6B68B7-4804-483D-84FF-D6E39A7DA6F9

P31

Q35641386-895C468A-60DB-4E3A-9F95-998A36BAAC45

P356

Q35641386-D7EABB96-62F0-4424-85E7-5FF712198D1A

P407

Q35641386-91479F00-5A4E-457E-B046-70B16D92D164

P433

Q35641386-0255E8DB-D534-4822-A2D7-BC9B85A3B740

P478

Q35641386-172555C7-AA64-4ECA-A900-F117B2A64EB2

P577

Q35641386-10C1EF0D-C3B4-4E1B-A402-FBE1AB8D6E34

P698

Q35641386-48A64FCE-5A64-419C-92AA-17C67E94AC78

P921

Q35641386-ADAE5B09-5675-4A6F-B368-474207CF86FE

P932

Q35641386-33DD0ADE-2450-4206-B506-1049F3634A10

P356

P1433

Journal of Virology

P1476

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

@en

P2093

Hayato Murakoshi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Gatanaga

http://www.w3.org/2001/XMLSchema#string

Madoka Koyanagi

http://www.w3.org/2001/XMLSchema#string

Masafumi Takiguchi

http://www.w3.org/2001/XMLSchema#string

Naoki Ishizuka

http://www.w3.org/2001/XMLSchema#string

Rie Maruyama

http://www.w3.org/2001/XMLSchema#string

Shinichi Oka

http://www.w3.org/2001/XMLSchema#string

Takayuki Chikata

http://www.w3.org/2001/XMLSchema#string

Takuya Naruto

http://www.w3.org/2001/XMLSchema#string

Tomohiro Akahoshi

http://www.w3.org/2001/XMLSchema#string

P2860

Design and pre-clinical evaluation of a universal HIV-1 vaccine

Statistical significance for genomewide studies

Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity

A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

HIV-1 group M conserved elements vaccine.

P304

5330-5339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00020-15

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25741000

http://www.w3.org/2001/XMLSchema#string

P921

P932

4442500

http://www.w3.org/2001/XMLSchema#string